Literature DB >> 29381395

Differential expression of miRNAs are associated with the insulin signaling pathway in preeclampsia and gestational hypertension.

Olive P Khaliq1, Saravanakumar Murugesan1, Jagidesa Moodley2, Irene Mackraj1.   

Abstract

OBJECTIVES: The objective of this study was to determine microRNAs (miRNAs) expression levels in placental tissue and serum samples from preeclampsia (PE) and gestational hypertensive (GH) patients. STUDY
DESIGN: Using a targeted qPCR method, the selected miRNAs putatively involved in the PE and GH were examined from normotensive (n = 32), PE (n = 32) and GH (n = 28) in South African women. Western blot analysis of protein expressions of AKT and PI3K was performed in the placental tissue of all three groups.
RESULTS: qPCR results of serum miR-222 expression levels showed a significant decrease in PE compared to GH and normotensive groups. miR-29a expression levels were significantly increased in PE and GH groups compared to normotensives. Serum expression levels of miR-181a in GH showed a significant increase compared to the PE and normotensive groups. Placental tissue expression levels of miR-181a were significantly increased in PE and GH groups compared to normotensives. Western blot results of placental tissue showed a decrease in the expression levels of AKT-serine and threonine in the PE groups compared to the normotensives and a significantly higher expression in the GH groups compared to normotensives. Phosphatidyl-inositol-3 kinase (PI3K) expression levels were significantly decreased in PE and GH groups compared to normotensives.
CONCLUSION: The present study, interestingly, demonstrates the differential expression of circulating miRNA in GH and a correlation between the expression levels of miRNAs with AKT/PI3K in the insulin signaling pathway, reinforcing the presence of metabolic dysregulation in PE and GH.

Entities:  

Keywords:  AKT-serine; Mirnas; gestational hypertension; phosphatidyl-inositol-3; preeclampsia

Mesh:

Substances:

Year:  2018        PMID: 29381395     DOI: 10.1080/10641963.2018.1431257

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  10 in total

1.  miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12.

Authors:  Yiwei Zhang; Juan Yan; Xiaowei Pan
Journal:  Pflugers Arch       Date:  2019-05-25       Impact factor: 3.657

2.  The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Authors:  Alejandra Abascal-Saiz; Marta Duque-Alcorta; Victoria Fioravantti; Eugenia Antolín; Eva Fuente-Luelmo; María Haro; María P Ramos-Álvarez; Germán Perdomo; José L Bartha
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

Review 3.  Epigenetic modification: a regulatory mechanism in essential hypertension.

Authors:  Mohammed Arif; Sakthivel Sadayappan; Richard C Becker; Lisa J Martin; Elaine M Urbina
Journal:  Hypertens Res       Date:  2019-03-13       Impact factor: 3.872

4.  NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension.

Authors:  Yunxia Guo; Zhaofang Liu; Ming Wang
Journal:  Cytotechnology       Date:  2021-01-04       Impact factor: 2.058

5.  Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells.

Authors:  Qian Chen; Sijia Jiang; Haihua Liu; Yue Gao; Xiaoxue Yang; Zhonglu Ren; Yunfei Gao; Lu Xiao; Haoyue Hu; Yanhong Yu; Xinping Yang; Mei Zhong
Journal:  Cell Death Dis       Date:  2020-07-27       Impact factor: 8.469

Review 6.  Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs.

Authors:  Laila Aryan; Lejla Medzikovic; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2020-04-06       Impact factor: 5.027

7.  The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort.

Authors:  Anja Elaine Sørensen; Mireille N M van Poppel; Gernot Desoye; Peter Damm; David Simmons; Dorte Møller Jensen; Louise Torp Dalgaard
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

Review 8.  Preeclamptic Women Have Disrupted Placental microRNA Expression at the Time of Preeclampsia Diagnosis: Meta-Analysis.

Authors:  Andja Cirkovic; Dejana Stanisavljevic; Jelena Milin-Lazovic; Nina Rajovic; Vedrana Pavlovic; Ognjen Milicevic; Marko Savic; Jelena Kostic Peric; Natasa Aleksic; Nikola Milic; Tamara Stanisavljevic; Zeljko Mikovic; Vesna Garovic; Natasa Milic
Journal:  Front Bioeng Biotechnol       Date:  2021-12-24

9.  Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia.

Authors:  Willie Lin; Sen-Wen Teng; Tzu-Yi Lin; Ronald Lovel; Hsin-Yu Sung; Wen-Ying Chang; Tang Bo-Chung Wu; Hsuan-Yu Chen; Le-Ming Wang; Steven W Shaw
Journal:  Diagnostics (Basel)       Date:  2022-06-23

Review 10.  From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.

Authors:  Sonya Frazier; Martin W McBride; Helen Mulvana; Delyth Graham
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.